Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors Meeting Abstract

  


Authors: Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
Abstract Title: Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
Meeting Title: 108th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title: Modern Pathology
Volume: 32
Issue: Suppl. 2
Meeting Dates: 2019 Mar 16-21
Meeting Location: National Harbor, MD
ISSN: 0893-3952
Publisher: Nature Research  
Date Published: 2019-03-01
Language: English
ACCESSION: WOS:000478915503357
PROVIDER: wos
PUBMED: 30886295
DOI: 10.1038/s41379-019-0244-6
Notes: Meeting Abstract: 1844 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    434 Rekhtman
  2. Marc Ladanyi
    1335 Ladanyi
  3. William D Travis
    750 Travis
  4. Mrinal M Gounder
    230 Gounder
  5. Charles Rudin
    496 Rudin
  6. Jennifer Lynn Sauter
    129 Sauter
  7. Azadeh Namakydoust
    22 Namakydoust
  8. Brie Elizabeth Kezlarian
    24 Kezlarian
Related MSK Work